Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.63 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 4/20 | 0.36 |
| ▸ | GABRD | O14764 | 4/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.36 |
| ▸ | GABRE | P78334 | 4/20 | 0.36 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2266575 | 1.00 | SLC7A5 (0.63) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL2895827 | 1.00 | SLC7A5 (0.63) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL7335221 | 1.00 | SLC7A5 (0.63) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL9135178 | 1.00 | SLC7A5 (0.63) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL4330500 | 1.00 | SLC7A5 (0.63) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL87358 | 1.00 | SLC7A5 (0.63) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| Hydrochloric Acid SCHEMBL7920996 | 0.97 | SLC7A5 (0.60) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| Hydrochloric Acid SCHEMBL7920991 | 0.97 | SLC7A5 (0.60) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| Hydrochloric Acid SCHEMBL9132421 | 0.97 | SLC7A5 (0.60) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| Sulfuric Acid SCHEMBL9403169 | 0.89 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 623 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028793-A | Fungicidal compositions | 先正达农作物保护股份公司 | 2026-05-12 | — | — | CN | claimed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| US-20250177537-A1 | AN ANTIBIOTIC, METHOD OF PREPARATION AND METHOD OF TREATMENT THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2025-06-05 | — | — | US | claimed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| CN-118265452-A | Fungicidal compositions | 先正达农作物保护股份公司 | 2024-06-28 | — | — | CN | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| CN-116426491-A | Preparation method for synthesizing AMA and derivatives thereof by double enzyme coupling | 中国药科大学 | 2023-07-14 | — | — | CN | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| EP-4161267-A1 | FUNGICIDAL COMPOSITIONS | Syngenta Crop Protection AG (CH) | 2023-04-12 | — | — | EP | claimed |
| US-20030130540-A1 | Process for producing carboxylic acids | E2V TECHNOLOGIES LIMITED (GB) | 2003-07-10 | — | — | US | claimed |
| EP-1088020-B1 | FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | USTAV MAKROMOLEKULARNI CHEMIE (CZ) | 2002-12-18 | — | — | EP | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| US-5886146-A | N-ACYLATED OR SULFONATED TRIPEPTIDES FROM PROLINE, ARGININE AND AMINO ACID WITH CARBOXY OR TETRAZOLE GROUP | CORVAS INTERNATIONAL, INC. (US) | 1999-03-23 | — | — | US | claimed |
| US-5326908-A | Process for the preparation of asparagine | NSC TECHNOLOGIES LLC | 1994-07-05 | — | — | US | claimed |
| US-5047401-A | Bone marrow transplants | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-09-10 | — | — | US | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIP, LNPEP, CSTB | SLC7A5 2179/4885SLC1A3 4201/4885SLC1A2 4780/4885 |
| US-20030130540-A1 | Process for producing carboxylic acids | ADH5, ADH1A, ADH1C | SLC7A5 1609/4885SLC1A3 3242/4885SLC1A2 2952/4885 |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIP, QPCT, QPCTL | SLC7A5 196/4885SLC1A3 685/4885SLC1A2 2572/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | SLC7A5 37/4885SLC1A3 404/4885SLC1A2 1464/4885 |
| US-20250177537-A1 | AN ANTIBIOTIC, METHOD OF PREPARATION AND METHOD OF TREATMENT THEREOF | BTD, CALCR, CA6 | SLC7A5 3318/4885SLC1A3 3681/4885SLC1A2 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.